@PSYCHObubu
bubu12 : ta toujours pas compris comment fonctionnait le site qui te sert de support
Adverse events from drugs and vaccines are common, but
underreported. Although 25% of ambulatory patients experience an adverse drug
event, less than 0.3% of all adverse drug events and 1-13% of serious events
are reported to the Food and Drug Administration (FDA).
Likewise, fewer than 1% of vaccine adverse events are reported.
Low reporting rates preclude or slow the
identification of “problem” drugs and vaccines that endanger public health. New
surveillance methods for drug and vaccine adverse effects are needed. Barriers
to reporting include a lack of clinician awareness, uncertainty about when and
what to report, as well as the burdens of reporting : reporting is not part of
clinicians’ usual workflow, takes time, and is duplicative. Proactive,
spontaneous, automated adverse event reporting imbedded within EHRs and other
information systems has the potential to speed the identification of problems
with new drugs and more careful quantification of the risks of older drugs.
Unfortunately,
there was never an opportunity to perform system performance assessments
because the necessary CDC contacts were no longer available and the CDC
consultants responsible for receiving data were no longer responsive to our
multiple requests to proceed with testing and evaluation.
Electronic Support for Public
Health–Vaccine Adverse Event Reporting System (ESP:VAERS)